Sussex Research is a leading global specialist carbohydrate synthesis including GalNAc, Glycan, Glycopeptide and Glycoconjugate synthesis. The company excels at the discovery and development of molecules that explore and exploit glycobiology or incorporate glycotechnology. Our unique carbohydrate product portfolio and synthetic capabilities enable researchers across a variety of scientific disciplines to readily explore and exploit novel molecules in order to enhance the therapeutic potential of lead molecules or advance drug development. We have enabled application of complex carbohydrate systems for drug discovery, drug delivery, drug targeting, carbohydrate-based vaccine development, immunotherapy, therapeutic enhancement, monoclonal antibody development and diagnostic/bio-analytical assay development.

Sussex Research offers a portfolio of diverse carbohydrate-based products and custom synthesis, as well as non-GLP analytical and bioanalytical services.